. Author manuscript; available in PMC: 2021 Nov 16.
Published in final edited form as: J Cancer Metastasis Treat. 2020 Mar 13;6:8. doi: 10.20517/2394-4722.2019.38
This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Figure 3.
Conceptual framework. PRO: patient-reported outcome; ICM: immune checkpoint modulators